Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 900.00K | $ 2.50M | $ 6.50M | $ 11.70M | $ 18.90M |
Total Assets | $ 514.80M | $ 485.70M | $ 463.80M | $ 439.90M | $ 453.80M |
Total Debt | $ 170.30M | $ 146.70M | $ 125.30M | $ 110.70M | $ 143.50M |
Net Debt | $ 169.40M | $ 144.20M | $ 118.80M | $ 99.00M | $ 124.60M |
Total Liabilities | $ 293.00M | $ 259.30M | $ 240.90M | $ 220.70M | $ 243.70M |
Stockholders Equity | $ 221.80M | $ 226.40M | $ 222.90M | $ 219.20M | $ 210.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |